EUVIMEDOpdag EUVIMED
Crossref

Psychiatric Disease and Medical Financial Burden Among Commercially Insured Adult Kidney Transplant Recipients in the United States

Lauren E Matevish, Yue Jiang, Alex R Jones, Zhuoran Yao, Ben Lippe, David Wojciechowski, Jigesh A Shah, Swee-Ling Levea, Parsia A Vagefi, Amit G Singal, Lisa B VanWagner, Sarah R Lieber and 1 more

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70517 ↗

At a glance

Journal article in Clinical Transplantation, 2026. Written by Lauren E Matevish and 12 co-authors. Institution: Department of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Major MEDLINE topics: Kidney Transplantation, Mental Disorders, Kidney Failure, Chronic, Postoperative Complications. Cited 1 times so far (Crossref); 46 references. Funded by: NCATS NIH HHS, National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Although psychiatric disorders after kidney transplantation (KT) are associated with adverse outcomes, the associated risk factors, treatment patterns, and financial burden remain poorly characterized. We sought to address these gaps by characterizing psychiatric diagnoses, their treatment, and patient financial liability in the first year following KT.

Methods

Adult KT recipients (KTRs) from 2006 to 2021 were identified using IQVIA PharMetrics Plus for Academics, a large population‐based commercial insurance claims database. Psychiatric diagnoses were defined using International Classification of Diseases‐Ninth Revision (ICD9)/Tenth Revision (ICD10) codes, and patient characteristics and total financial liability within the first year post‐transplant were compared between KTRs with and without a psychiatric diagnosis. Regression analyses identified factors associated with post‐KT psychiatric diagnoses.

Results

Among 2148 KTRs, 291 (13.5%) had a prevalent psychiatric diagnosis within 1 year post‐KT; 102 (35.1%) were incident diagnoses. Prevalence varied by KTR transplant era, with 17.3% of the 2014–2017 cohort having an ICD9/10 psychiatric diagnosis code in the year following KT. The strongest factor associated with post‐KT psychiatric diagnosis was a pre‐existing psychiatric diagnosis (aOR 21.68), while incident diagnoses were significantly associated with hospital length of stay >1 week (aOR 2.10). Early post‐KT complications were also associated with subsequent psychiatric diagnosis (aOR 1.96; 95% CI 1.23–3.07). Only half of those with a psychiatric diagnosis ( N = 148/291) had a claim for treatment (i.e., pharmacotherapy and/or psychotherapy). The median total patient liability for 1 year of post‐KT care was $2100 (IQR $700–8200), and not significantly different between those with and without psychiatric diagnoses ( p = 0.29).

Conclusions

Despite higher healthcare utilization in KTRs with psychiatric diagnoses, median total financial liability was not significantly different between groups. Clinicians should be attentive to risk factors for psychiatric complications and consider protocols to screen symptoms among high‐risk individuals.

Subjects

MeSH terms (MEDLINE)

Kidney TransplantationMental DisordersKidney Failure, ChronicPostoperative ComplicationsInsurance, HealthTransplant RecipientsCost of IllnessHumansFemaleMaleMiddle AgedFollow-Up StudiesAdultUnited StatesRisk FactorsPrognosisRetrospective Studies

Author keywords

kidney transplantpatient costpsychiatric diseaserecipient outcomes

Authors and institutions

  • Department of Surgery, Division of Surgical Transplantation, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Statistical Science, Duke University, Durham, North Carolina, USA.
  • Department of Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Psychiatry, Division of Psychology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Funding

  • NCATS NIH HHS
  • National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK)

Cite

APA

Matevish, L. E., Jiang, Y., Jones, A. R., Yao, Z., Lippe, B., Wojciechowski, D., Shah, J. A., Levea, S. L., Vagefi, P. A., Singal, A. G., VanWagner, L. B., Lieber, S. R., & Patel, M. S. (2026). Psychiatric Disease and Medical Financial Burden Among Commercially Insured Adult Kidney Transplant Recipients in the United States. Clinical Transplantation. https://doi.org/10.1111/ctr.70517

Vancouver

Matevish LE, Jiang Y, Jones AR, Yao Z, Lippe B, Wojciechowski D, et al. Psychiatric Disease and Medical Financial Burden Among Commercially Insured Adult Kidney Transplant Recipients in the United States. Clinical Transplantation. 2026. doi:10.1111/ctr.70517

BibTeX
@article{Matevish2026,
  author = {Matevish, Lauren E and Jiang, Yue and Jones, Alex R and Yao, Zhuoran and Lippe, Ben and Wojciechowski, David and Shah, Jigesh A and Levea, Swee-Ling and Vagefi, Parsia A and Singal, Amit G and VanWagner, Lisa B and Lieber, Sarah R and Patel, Madhukar S},
  title = {Psychiatric Disease and Medical Financial Burden Among Commercially Insured Adult Kidney Transplant Recipients in the United States},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70517}
}
Start for free →